Immune checkpoint inhibitors for first‐line treatment of advanced non‐small‐cell lung cancer: A systematic review and network meta‐analysis

OBJECTIVE: Currently, several immune checkpoint inhibitors (ICIs) treatment for advanced non‐small‐cell lung cancer (NSCLC) have been investigated; their overall efficacy and safety remain unclear. METHODS: We searched electronic databases such as PubMed, EMBASE, and the Cochrane library. The random...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Tzu‐Rong, Lin, Hung‐Hong, Tsai, Fang‐Pei, Wu, Ta‐Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563153/
https://www.ncbi.nlm.nih.gov/pubmed/34545685
http://dx.doi.org/10.1111/1759-7714.14148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563153/
https://www.ncbi.nlm.nih.gov/pubmed/34545685
http://dx.doi.org/10.1111/1759-7714.14148

Ejemplares similares